Literature DB >> 6485689

Serum thyroglobulin in differentiated thyroid carcinoma.

U B Ericsson, L Tegler, S Lennquist, S B Christensen, E Ståhl, J I Thorell.   

Abstract

Serum thyroglobulin (S-Tg) concentrations were measured in 262 patients with differentiated thyroid carcinoma. Analysis of S-Tg with respect to histology showed that the follicular variety of carcinoma had the highest S-Tg values preoperatively and postoperatively when metastases were found. The S-Tg levels during thyroxine treatment accurately predicted the results of 131-I total body scan in all but two cases. In another patient both S-Tg and total body iodine scan were negative at the time when metastases were discovered at X-ray examination. All but two patients with negative scan had S-Tg less than 10 micrograms/l, whereas patients with metastases had values between 11 and greater than 5000 micrograms/l. In patients with residual thyroid bed uptake the S-Tg range was from less than 2 to 84 micrograms/l. The authors conclude that determination of the S-Tg level can replace total body iodine scan in most patients who have undergone ablative therapy for differentiated thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6485689

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  6 in total

1.  The value of intraoperative scintigraphy as a routine procedure in thyroid carcinoma.

Authors:  S Lennquist; J Persliden; S Smeds
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

2.  Intraoperative scintigraphy in surgical treatment of thyroid carcinoma: evaluation of a new technique.

Authors:  S Lennquist; J Persliden; S Smeds
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Reduced serum thyroglobulin response to bovine TSH in malignant hypofunctioning solid thyroid nodules: comparison to benign nodular disease.

Authors:  Z Leite; P Carneiro; A Halpern; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

4.  Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.

Authors:  A J Van Herle; P D Rosenblit; T L Van Herle; P Van Herle; M Greipel; K Kellett
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

5.  Predictive value of serum thyroglobulin in treated patients with differentiated thyroid carcinoma.

Authors:  D C Stephen; M S Seshadri; R Oommen; A Nair; S Swaminathan; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  1999-01

6.  Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.

Authors:  S O Thoresen; O Myking; E Glattre; K Rootwelt; A Andersen; O P Foss
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.